Call for Abstracts

The Scientific Program Committee invites prospective authors to submit abstracts for oral and poster presentations to be presented at the 17th Asia-Pacific Federation for Clinical Biochemistry and Laboratory Medicine (APFCB) Congress being held at ICC Sydney, Australia.

Abstract submissions can be made via the Abstract Submission Portal below: Submit Your Abstract for a Presentation

All abstracts must follow the instructions listed below and be submitted online by 23:59 (AEST) 2 May 2024. Please note that the closing date for abstract submission will not be extended.

All enquiries regarding abstracts for APFCB 2024 should be emailed to the Congress Secretariat at

Congress Theme

Laboratory Medicine, Bridging Personalised Care and Public Health

Abstract Submission Details and Guidelines

  • Abstracts are to be considered for an Oral or Poster Presentation
  • All abstracts must be submitted online
  • Abstracts must be submitted online and typed directly into the submission form
  • All abstracts submissions are allowed a maximum of 300 words in the body of the abstract
  • Abstracts over 300 words in the body of the abstract will not be considered
  • Only abstracts submitted in English will be reviewed
  • Notifications will be emailed only to the submitting author
  • Authors are welcome to submit multiple abstracts
  • Authors should use the following headings
    • Introduction (the study objectives)
    • Methods (a brief statement of methods used)
    • Results (a summary of results, including statistical significance in text; do not include tables or figures. It is not sufficient to say that results will be discussed)
    • Conclusions (a brief but clear conclusion drawn from the results shown)
  • Abstracts should not include tables or figures
  • Abstracts should be thoroughly checked for spelling and grammar
  • There is no fee for submitting an abstract
  • Abstracts must be submitted by 23:59 (AEST) 2 May 2024 for consideration by the Committee

Themes for Submissions

The Scientific Program Committee warmly invites you to submit an abstract to the following themes running at the Congress.

  • Regional issues
  • Public Health
  • Neonatal/Paediatric disease
  • Molecular Diagnostics
  • Chronic Diseases
  • General Biochemistry
  • Laboratory Medicine
  • Endocrinology
  • Laboratory Management
  • Workforce Development
  • Metabolic medicine
  • Immunology
  • Hematology/Microbiology
  • Quality Assurance/Quality Control

During the abstract submission process, you will be required to provide;

  • Title of abstract
  • Presentation type – oral or poster
  • First and last names of all authors
  • Full affiliations for all authors
  • Abstract content of maximum 300 words in the body of the abstract

Once you have submitted your abstract, you will receive an automated submission successful email.


  • Abstracts must be typed in English
  • Abstracts must be typed into the online submission Form.
  • Word Limit: maximum 300 words in the body of the abstract. Abstracts over this limit will be asked to be revised to the word limit.
  • Do not include tables or figures.
  • If you wish to include QAP data in your abstract you must obtain prior written consent from RCPA Quality Assurance Programs. Please send your request to Mr Peter Graham at
  • Abstracts will be reproduced as submitted by the author with minimal editing.
  • Abstracts should be thoroughly checked for correct spelling and grammar before finalising the submission.
  • Please ensure that you include all information requested in the online abstract submission form.
  • The organising committee reserves the right to decline unsuitable topics.

Please note all accepted presenters must register to attend the Congress. If you have not registered and paid by 23:59 (AEST) Thursday 18 July 2024 your paper may be taken out of the program.

Please note Posters must be displayed for the entire three days of the Congress. Poster presenters must be present at their poster on their designated day.

Format & Content

Word Limit in body of abstract

(excludes title, authors, affiliations)

300 words

Do not include tables or figures.

Abstracts over 300 words in the body or with tables in the abstract will not be accepted. Your abstract will be sent back to you to reduce to the 300 word limit and remove the tables.

Font Type

Times New Roman

Font Size

12 point

Line Spacing




Please avoid the use of brand / company names in the title

Left justify


(leave one line space between authors & title)

Initials then Surname.

Presenting author is bold and underlined.

If more than one author & address insert a superscript number at the end of the surname after a comma (for each author).

Left justify

Author(s) Address

(next line under authors)

Include institution, city, state, postcode and country. (Do not include department names).

If more than one author / address designate each author’s address by a superscripted number before the address.

Left justify

Email address

Insert presenting author’s email address

Left justify

Main body

(leave one line space between email address & main body)

The abstract should be an informative document able to stand alone in its content and meaning

The main body should be presented under the following headings:

  • Introduction (the study objectives)
  • Methods (a brief statement of methods used)
  • Results (a summary of results, including statistical significance in text; do not include tables or figures. It is not sufficient to say that results will be discussed)
  • Conclusions (a brief but clear conclusion drawn from the results shown)

The content must not have been previously published.

Use abbreviations with restraint. Terms must be spelt fully the first time they appear.

Left justify

Abstract Acknowledgement

A confirmation email acknowledging receipt of your abstract submission will be automatically emailed to you once you have completed the online abstract submission. If you do not receive this confirmation email, or wish to make changes to your submitted abstract*, please contact the Congress Secretariat.

If you wish to submit an additional abstract you can log back into the submission form by clicking on the submission link and signing in with your email and password.

NOTE: If you wish to edit your abstract note that only ‘saved as draft’ abstracts can be edited online until the closing date. If your fully submitted your abstract and wish to make changes please email with the changes.

Please note that all correspondence will be sent to the e-mail address from which the submitted abstract was received.

Authors will be advised whether their abstract/s have been accepted from mid-June 2024.

Terms and Conditions

The submission of an abstract indicates an understanding of the following terms and conditions for participation in APFCB 2024;

  • All authors must approve of submitting this work for presentation
  • At least one author needs to be available to present if selected
  • All abstracts are to be within 300 words in the body of the abstract
  • There is only one Presenting Author per abstract submission
  • To be accepted as an abstract, Presenting Authors must be registered for the Congress by 23:59 (AEST) Thursday 18 July 2024
  • All abstracts must be submitted by 23:59 (AEST) Thursday 2 May 202 to be considered

By submitting an abstract you are consenting to the publication of your abstract, if accepted, in the Congress App, Handbook and in the Clinical Biochemists Reviews (subject to CBR Editorial team approval).

All submissions must complete the Copyright and Conflict of Interest section in the online submission form, as part of the submission process.

The Author(s) assign to the Association and its successors all rights, title and interest in the Abstract now or later protected (including by any renewal, extension or reversion of copyright) by Copyright Laws of Australia and New Zealand. If this Abstract is not published within twelve months from the date above, this Assignment is void.

If portions of this Abstract have been previously published, permission has been obtained for publication in the Clinical Biochemist Reviews and the Author(s) are submitting a copy of the permission release and copy for credit lines with this Abstract. The Association can edit, adapt or change this Abstract at its sole discretion.

The Association grants to Authors the royalty-free right to republish the Abstract in any book of which they are the Author or Editor, provided that any republication includes a clear written notice of the Association’s copyright. All rights assigned to the Association shall inure to the benefit of all persons, firms and corporations who acquire from the Association any right to distribute, transmit, exhibit or exploit the product to the Association and such product may be released under any company or trade name, brand, trademark or other designation desired by the Association. This assignment shall be governed by and construed under the laws of the State of Western Australia.

A conflict of interest arises when speakers/authors have interests that are not fully apparent and that may influence their judgement in such a way that an independent observer might reasonably question whether the statements made are influenced by their own interests, and or that which, when revealed later, would make a reasonable reader/member of the audience feel misled or deceived. They may be personal, commercial, political, academic or financial. Financial interests may include employment, research funding and stock or share ownership, payment for lectures or travel, consultancies and company support of staff.

All speakers/authors must disclose, on the disclosure of interest form, all relationships that could be viewed as presenting a potential conflict of interest including any affiliation with or financial involvement in, or payments or other assistance in kind from, any organisation with direct interest in the subject matter. The reason for requesting disclosure of possible conflict of interest is not to exclude speakers/authors, but to inform the audience/reader so they may decide for themselves whether or not a presentation/article may be biased.

APFCB 2024 reserves the right to remove from any publication any abstract that does not comply with the above.


Please direct all abstract enquiries to:
APFCB 2024 Congress Secretariat
ICMS Australasia